Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,670,220
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
53,808,832
-
Shares change
-
+1,381,556
-
Total reported value, excl. options
-
$1,112,728,096
-
Value change
-
+$17,661,819
-
Put/Call ratio
-
215%
-
Number of buys
-
112
-
Number of sells
-
80
-
Price
-
$20.68
Institutional Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q4 2022
As of 31 Dec 2022 Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) had 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 53,808,832 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, PFM Health Sciences, LP, Octagon Capital Advisors LP, BVF INC/IL, Invus Financial Advisors, LLC, Boxer Capital, LLC, and PICTET ASSET MANAGEMENT SA.
This table shows 199 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.